Topics Archive - COVID-19 Pharmacology Resource Center

Supported by

Supported by

- Adverse effect of ivermectin?
- Convalescent plasma to treat COVID-19?
  Started by J WC in: General Questions
- 2
  2
- Waves of COVID-19?
  Started by J WC in: General Questions
- 2
  2
- Adverse effect of ivermectin?
  Started by J WC in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14)
- 1
  2
- Simulate dosage forms?
  Started by J WC in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14)
- 1
  1
- Impact of polymorphism?
  Started by J WC in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14)
- 1
  2
- Most advanced platform for molecule mordeling?
  Started by J WC in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14)
- 1
  2
- High dose of CQ in short time period?
  Started by J WC in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14)
- 1
  3
- Which drugs are high priority?
  Started by J WC in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14)
- 1
  2
- Combo approach to treat COVID?
  Started by J WC in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14)
- 1
  2
- Which do we choose to carry forward?
  Started by J WC in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14)
- 1
  2
- Values from the site of action from literature
  Started by J WC in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14)
- 1
  2
- Webinar Q: Unbound fraction in viral IC50 assays
  Started by J WC in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14)
- 1
  2
- Webinar Q: 2 or 3 compartmental model comparison
  Started by J WC in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14)
- 1
  2
- COV IC50 obtained in vivo comparable to C(t) at SOA
  Started by J WC in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14)
- 1
  2
- Webinar Q: How to achieve a well designed study
  Started by J WC in: Q&A from Webinar: Model-informed Drug Repurposing – Applications for COVID-19 (May 14)
- 1
  2